Pacific Biosciences of California, Inc. (PACB)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 4.61B |
| Enterprise Value | 4.48B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 35.23 |
| Price/Book (mrq) | 5.48 |
| Enterprise Value/Revenue | 36.83 |
| Enterprise Value/EBITDA | -39.68 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.12 |
| 52-Week Change 3 | -69.37% |
| S&P500 52-Week Change 3 | 18.79% |
| 52 Week High 3 | 53.69 |
| 52 Week Low 3 | 10.61 |
| 50-Day Moving Average 3 | 21.51 |
| 200-Day Moving Average 3 | 26.89 |
Share Statistics
| Avg Vol (3 month) 3 | 2.88M |
| Avg Vol (10 day) 3 | 5.53M |
| Shares Outstanding 5 | 220.6M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 217.71M |
| % Held by Insiders 1 | 6.03% |
| % Held by Institutions 1 | 84.24% |
| Shares Short (Dec. 30, 2021) 4 | 19.91M |
| Short Ratio (Dec. 30, 2021) 4 | 7.55 |
| Short % of Float (Dec. 30, 2021) 4 | 11.34% |
| Short % of Shares Outstanding (Dec. 30, 2021) 4 | 9.03% |
| Shares Short (prior month Nov. 29, 2021) 4 | 16.97M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | N/A |
| Trailing Annual Dividend Yield 3 | N/A |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec. 30, 2020 |
| Most Recent Quarter (mrq) | Sep. 29, 2021 |
Profitability
| Profit Margin | -30.39% |
| Operating Margin (ttm) | -109.36% |
Management Effectiveness
| Return on Assets (ttm) | -7.12% |
| Return on Equity (ttm) | -7.62% |
Income Statement
| Revenue (ttm) | 121.63M |
| Revenue Per Share (ttm) | 0.62 |
| Quarterly Revenue Growth (yoy) | 82.80% |
| Gross Profit (ttm) | 32.57M |
| EBITDA | -126.31M |
| Net Income Avi to Common (ttm) | -36.96M |
| Diluted EPS (ttm) | -0.19 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.08B |
| Total Cash Per Share (mrq) | 4.89 |
| Total Debt (mrq) | 953M |
| Total Debt/Equity (mrq) | 113.34 |
| Current Ratio (mrq) | 20.32 |
| Book Value Per Share (mrq) | 3.81 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -93.73M |
| Levered Free Cash Flow (ttm) | -111.18M |
